https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/chemical-analysis-biocompatibility-assessment-medical-devices<\/a><\/p>\n\nAs described in FDA\u2019s biocompatibility guidance \u201cUse of International Standard ISO 10993-1<\/em>, \u2018Biological evaluation of medical devices \u2013 Part 1: Evaluation and testing within a risk management process<\/em>,\u2019\u201d biocompatibility is evaluated through a risk management process. Potential biocompatibility risks are identified through risk assessment of a device and then mitigated using relevant information. <\/p>\n\nChemical characterization is used to characterize the chemicals that may be released from the medical device to the body. Additionally, chemical characterization can be considered as an alternative to biological testing for evaluating certain biocompatibility endpoints when used in conjunction with toxicological risk assessment (TRA). <\/p>\n\n
Given that current biocompatibility guidelines do not specify detailed methodology on how to perform extractables studies and chemical analysis of device extracts, inconsistent analytical chemistry reports and deficiencies are frequently identified. This new draft guideline provides manufactures different approaches for conducting chemical characterization as part of the biocompatibility assessment for a device. More specifically, it promotes consistency and reliability of analytical chemistry studies and to facilitate more efficient review of these studies in premarket submissions, while aligning with ISO 10993- 18 and other relevant consensus standards where applicable. <\/p>\n","protected":false},"excerpt":{"rendered":"
FDA has just released a draft guidance for Chemical Analysis for Biocompatibility Assessment of Medical Devices. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/chemical-analysis-biocompatibility-assessment-medical-devices As described in FDA\u2019s biocompatibility guidance \u201cUse of International Standard ISO 10993-1, \u2018Biological evaluation of medical devices \u2013 Part 1: Evaluation and testing within a risk management process,\u2019\u201d biocompatibility is evaluated through a risk management process. Potential biocompatibility … FDA draft guidance for Chemical Analysis for Biocompatibility Assessment of Medical Devices<\/span>“>Continue reading FDA draft guidance for Chemical Analysis for Biocompatibility Assessment of Medical Devices<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":1544,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[38],"tags":[],"class_list":["post-1545","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"yoast_head":"\nFDA draft guidance for Chemical Analysis for Biocompatibility Assessment of Medical Devices - Dalia Global<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA draft guidance for Chemical Analysis for Biocompatibility Assessment of Medical Devices - Dalia Global\" \/>\n<meta property=\"og:description\" content=\"FDA has just released a draft guidance for Chemical Analysis for Biocompatibility Assessment of Medical Devices. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/chemical-analysis-biocompatibility-assessment-medical-devices As described in FDA\u2019s biocompatibility guidance \u201cUse of International Standard ISO 10993-1, \u2018Biological evaluation of medical devices \u2013 Part 1: Evaluation and testing within a risk management process,\u2019\u201d biocompatibility is evaluated through a risk management process. Potential biocompatibility … Continue reading FDA draft guidance for Chemical Analysis for Biocompatibility Assessment of Medical Devices\" \/>\n<meta property=\"og:url\" content=\"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/\" \/>\n<meta property=\"og:site_name\" content=\"Dalia Global\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-31T17:17:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-12T12:45:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/daliaglobal.com\/wp-content\/uploads\/revslider\/home-slider-11\/slider-11-b-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dalia Global\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dalia Global\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/\"},\"author\":{\"name\":\"Dalia Global\",\"@id\":\"https:\/\/daliaglobal.com\/en\/#\/schema\/person\/0ff7ddbb852c7dce86efb6c4bce15c49\"},\"headline\":\"FDA draft guidance for Chemical Analysis for Biocompatibility Assessment of Medical Devices\",\"datePublished\":\"2024-10-31T17:17:26+00:00\",\"dateModified\":\"2026-01-12T12:45:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/\"},\"wordCount\":219,\"image\":{\"@id\":\"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/daliaglobal.com\/wp-content\/uploads\/revslider\/home-slider-11\/slider-11-b-1.jpg\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/\",\"url\":\"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/\",\"name\":\"FDA draft guidance for Chemical Analysis for Biocompatibility Assessment of Medical Devices - Dalia Global\",\"isPartOf\":{\"@id\":\"https:\/\/daliaglobal.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/daliaglobal.com\/wp-content\/uploads\/revslider\/home-slider-11\/slider-11-b-1.jpg\",\"datePublished\":\"2024-10-31T17:17:26+00:00\",\"dateModified\":\"2026-01-12T12:45:14+00:00\",\"author\":{\"@id\":\"https:\/\/daliaglobal.com\/en\/#\/schema\/person\/0ff7ddbb852c7dce86efb6c4bce15c49\"},\"breadcrumb\":{\"@id\":\"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/#primaryimage\",\"url\":\"https:\/\/daliaglobal.com\/wp-content\/uploads\/revslider\/home-slider-11\/slider-11-b-1.jpg\",\"contentUrl\":\"https:\/\/daliaglobal.com\/wp-content\/uploads\/revslider\/home-slider-11\/slider-11-b-1.jpg\",\"width\":1920,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/daliaglobal.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA draft guidance for Chemical Analysis for Biocompatibility Assessment of Medical Devices\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/daliaglobal.com\/en\/#website\",\"url\":\"https:\/\/daliaglobal.com\/en\/\",\"name\":\"Dalia Global\",\"description\":\"Smart Toxicology\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/daliaglobal.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/daliaglobal.com\/en\/#\/schema\/person\/0ff7ddbb852c7dce86efb6c4bce15c49\",\"name\":\"Dalia Global\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/daliaglobal.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/4cd8dd222bff156f630f04dce8e27ac209d4aa19ccb99634970b7055aa400e61?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/4cd8dd222bff156f630f04dce8e27ac209d4aa19ccb99634970b7055aa400e61?s=96&d=mm&r=g\",\"caption\":\"Dalia Global\"},\"sameAs\":[\"https:\/\/new.daliaglobal.com\"],\"url\":\"https:\/\/daliaglobal.com\/en\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA draft guidance for Chemical Analysis for Biocompatibility Assessment of Medical Devices - Dalia Global","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/","og_locale":"en_US","og_type":"article","og_title":"FDA draft guidance for Chemical Analysis for Biocompatibility Assessment of Medical Devices - Dalia Global","og_description":"FDA has just released a draft guidance for Chemical Analysis for Biocompatibility Assessment of Medical Devices. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/chemical-analysis-biocompatibility-assessment-medical-devices As described in FDA\u2019s biocompatibility guidance \u201cUse of International Standard ISO 10993-1, \u2018Biological evaluation of medical devices \u2013 Part 1: Evaluation and testing within a risk management process,\u2019\u201d biocompatibility is evaluated through a risk management process. Potential biocompatibility … Continue reading FDA draft guidance for Chemical Analysis for Biocompatibility Assessment of Medical Devices","og_url":"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/","og_site_name":"Dalia Global","article_published_time":"2024-10-31T17:17:26+00:00","article_modified_time":"2026-01-12T12:45:14+00:00","og_image":[{"width":1920,"height":900,"url":"https:\/\/daliaglobal.com\/wp-content\/uploads\/revslider\/home-slider-11\/slider-11-b-1.jpg","type":"image\/jpeg"}],"author":"Dalia Global","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dalia Global","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/#article","isPartOf":{"@id":"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/"},"author":{"name":"Dalia Global","@id":"https:\/\/daliaglobal.com\/en\/#\/schema\/person\/0ff7ddbb852c7dce86efb6c4bce15c49"},"headline":"FDA draft guidance for Chemical Analysis for Biocompatibility Assessment of Medical Devices","datePublished":"2024-10-31T17:17:26+00:00","dateModified":"2026-01-12T12:45:14+00:00","mainEntityOfPage":{"@id":"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/"},"wordCount":219,"image":{"@id":"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/#primaryimage"},"thumbnailUrl":"https:\/\/daliaglobal.com\/wp-content\/uploads\/revslider\/home-slider-11\/slider-11-b-1.jpg","articleSection":["Blog"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/","url":"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/","name":"FDA draft guidance for Chemical Analysis for Biocompatibility Assessment of Medical Devices - Dalia Global","isPartOf":{"@id":"https:\/\/daliaglobal.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/#primaryimage"},"image":{"@id":"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/#primaryimage"},"thumbnailUrl":"https:\/\/daliaglobal.com\/wp-content\/uploads\/revslider\/home-slider-11\/slider-11-b-1.jpg","datePublished":"2024-10-31T17:17:26+00:00","dateModified":"2026-01-12T12:45:14+00:00","author":{"@id":"https:\/\/daliaglobal.com\/en\/#\/schema\/person\/0ff7ddbb852c7dce86efb6c4bce15c49"},"breadcrumb":{"@id":"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/#primaryimage","url":"https:\/\/daliaglobal.com\/wp-content\/uploads\/revslider\/home-slider-11\/slider-11-b-1.jpg","contentUrl":"https:\/\/daliaglobal.com\/wp-content\/uploads\/revslider\/home-slider-11\/slider-11-b-1.jpg","width":1920,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/daliaglobal.com\/en\/fda-draft-guidance-for-chemical-analysis-for-biocompatibility-assessment-of-medical-devices\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/daliaglobal.com\/en\/"},{"@type":"ListItem","position":2,"name":"FDA draft guidance for Chemical Analysis for Biocompatibility Assessment of Medical Devices"}]},{"@type":"WebSite","@id":"https:\/\/daliaglobal.com\/en\/#website","url":"https:\/\/daliaglobal.com\/en\/","name":"Dalia Global","description":"Smart Toxicology","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/daliaglobal.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/daliaglobal.com\/en\/#\/schema\/person\/0ff7ddbb852c7dce86efb6c4bce15c49","name":"Dalia Global","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/daliaglobal.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/4cd8dd222bff156f630f04dce8e27ac209d4aa19ccb99634970b7055aa400e61?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4cd8dd222bff156f630f04dce8e27ac209d4aa19ccb99634970b7055aa400e61?s=96&d=mm&r=g","caption":"Dalia Global"},"sameAs":["https:\/\/new.daliaglobal.com"],"url":"https:\/\/daliaglobal.com\/en\/"}]}},"_links":{"self":[{"href":"https:\/\/daliaglobal.com\/en\/wp-json\/wp\/v2\/posts\/1545","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/daliaglobal.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/daliaglobal.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/daliaglobal.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/daliaglobal.com\/en\/wp-json\/wp\/v2\/comments?post=1545"}],"version-history":[{"count":1,"href":"https:\/\/daliaglobal.com\/en\/wp-json\/wp\/v2\/posts\/1545\/revisions"}],"predecessor-version":[{"id":1546,"href":"https:\/\/daliaglobal.com\/en\/wp-json\/wp\/v2\/posts\/1545\/revisions\/1546"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/daliaglobal.com\/en\/wp-json\/wp\/v2\/media\/1544"}],"wp:attachment":[{"href":"https:\/\/daliaglobal.com\/en\/wp-json\/wp\/v2\/media?parent=1545"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/daliaglobal.com\/en\/wp-json\/wp\/v2\/categories?post=1545"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/daliaglobal.com\/en\/wp-json\/wp\/v2\/tags?post=1545"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}